ArticleHepatology (Baltimore, Md.)2019

Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver Cancer.

Roslin Y Docta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.